$135 Million is the total value of Meditor Group Ltd's 3 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 91.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EXEL | Sell | EXELIXIS INC | $64,570,000 | -7.5% | 10,533,384 | -12.2% | 47.71% | +384.5% |
| ALKS | Sell | ALKERMES PLC | $41,906,000 | -20.6% | 1,030,639 | -34.4% | 30.96% | +316.0% |
| VVUS | Sell | VIVUS INC | $28,862,000 | -26.2% | 3,178,616 | -24.4% | 21.33% | +286.5% |
| HTZ | Exit | HERTZ GLOBAL HOLDINGS INC | $0 | – | -12,000 | -100.0% | -0.04% | – |
| INFN | Exit | INFINERA CORP | $0 | – | -24,400 | -100.0% | -0.04% | – |
| GTE | Exit | GRAN TIERRA ENERGY INC | $0 | – | -63,000 | -100.0% | -0.06% | – |
| CCL | Exit | CARNIVAL CORPctf | $0 | – | -45,600 | -100.0% | -0.21% | – |
| HAL | Exit | HALLIBURTON CO | $0 | – | -31,000 | -100.0% | -0.21% | – |
| MU | Exit | MICRON TECHNOLOGY INC | $0 | – | -155,000 | -100.0% | -0.38% | – |
| DAL | Exit | DELTA AIR LINES INC | $0 | – | -124,000 | -100.0% | -0.41% | – |
| BAC | Exit | BANK OF AMERICA CORP | $0 | – | -244,000 | -100.0% | -0.48% | – |
| VALE | Exit | VALE SA-SP ADRadr | $0 | – | -219,400 | -100.0% | -0.48% | – |
| APC | Exit | ANADARKO PETROLEUM CORP | $0 | – | -42,000 | -100.0% | -0.55% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -55,100 | -100.0% | -0.56% | – |
| PACD | Exit | PACIFIC DRILLING SA | $0 | – | -365,100 | -100.0% | -0.57% | – |
| SHPG | Exit | SHIRE PLC-ADRadr | $0 | – | -70,000 | -100.0% | -1.18% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -1,050,000 | -100.0% | -1.68% | – |
| LBTYK | Exit | LIBERTY GLOBAL PLC-SERIES Ccl c | $0 | – | -169,254 | -100.0% | -1.80% | – |
| OREX | Exit | OREXIGEN THERAPEUTICS INC | $0 | – | -2,100,000 | -100.0% | -1.82% | – |
| WCRX | Exit | WARNER CHILCOTT PLC-CLASS A | $0 | – | -566,000 | -100.0% | -1.83% | – |
| AAPL | Exit | APPLE INC | $0 | – | -30,000 | -100.0% | -2.02% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -1,450,000 | -100.0% | -2.14% | – |
| UHS | Exit | UNIVERSAL HEALTH SERVICES-Bcl b | $0 | – | -210,000 | -100.0% | -2.22% | – |
| ITMN | Exit | INTERMUNE INC | $0 | – | -1,025,000 | -100.0% | -2.22% | – |
| SPY | Exit | SPDR S&P 500 ETF TRUSTetf | $0 | – | -107,708 | -100.0% | -2.55% | – |
| ISIS | Exit | ISIS PHARMACEUTICALS INC | $0 | – | -490,000 | -100.0% | -2.59% | – |
| DDS | Exit | DILLARDS INC-CL Acl a | $0 | – | -245,000 | -100.0% | -2.70% | – |
| 6107SC | Exit | URS CORP | $0 | – | -377,324 | -100.0% | -2.86% | – |
| GOOGL | Exit | GOOGLE INC-CL Acl a | $0 | – | -23,452 | -100.0% | -2.90% | – |
| HPQ | Exit | HEWLETT-PACKARD CO | $0 | – | -1,156,423 | -100.0% | -3.42% | – |
| LIFE | Exit | LIFE TECHNOLOGIES CORP | $0 | – | -427,000 | -100.0% | -4.51% | – |
| NYX | Exit | NYSE EURONEXT | $0 | – | -776,070 | -100.0% | -4.59% | – |
| BKS | Exit | BARNES & NOBLE INC | $0 | – | -2,850,000 | -100.0% | -5.20% | – |
| JCPNQ | Exit | J.C. PENNEY CO INC | $0 | – | -4,500,000 | -100.0% | -5.59% | – |
| ONXX | Exit | ONYX PHARMACEUTICALS INC | $0 | – | -435,000 | -100.0% | -7.65% | – |
| MRK | Exit | MERCK & CO. INC. | $0 | – | -1,746,600 | -100.0% | -11.73% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-01-21
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| EXELIXIS INC | 43 | Q4 2023 | 88.9% |
| ALKERMES PLC | 31 | Q4 2020 | 62.6% |
| ISHARES MSCI INDIA ETF | 31 | Q4 2023 | 5.5% |
| WISDOMTREE INDIA EARNINGS FUND | 31 | Q4 2023 | 5.5% |
| ESPERION THERAPEUTICS INC | 27 | Q4 2023 | 34.4% |
| VIVUS INC | 15 | Q4 2016 | 21.3% |
| CELLDEX THERAPEUTICS | 14 | Q2 2020 | 2.7% |
| PROSHARES ULTRAPRO SHORT S&P500 | 4 | Q4 2017 | 3.8% |
| PROSHARES ULTRASHORT S&P500 | 4 | Q4 2017 | 3.0% |
| PROSHARES ULTRASHORT S&P 500 ETF | 3 | Q3 2019 | 0.8% |
View Meditor Group Ltd's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| EXELIXIS, INC. | April 09, 2019 | 15,001,073 | 5.0% |
| VIVUS INC | December 19, 2012 | 5,002,896 | 5.0% |
| VIVUS INC | March 21, 2012 | 6,177,500 | 6.3% |
| VION PHARMACEUTICALS INC | February 15, 2008 | 5,736,200 | 7.6% |
| CYPRESS BIOSCIENCE INC | September 26, 2007 | 1,864,645 | 5.0% |
| ONYX PHARMACEUTICALS INC | September 12, 2007 | 2,627,800 | 4.8% |
| ACUSPHERE INC | July 26, 2007 | 1,839,421 | 4.0% |
| NOVACEA INC | June 11, 2007 | 800,000 | 3.4% |
| ATHEROGENICS INC | May 02, 2007 | 1,361,800 | 3.5% |
View Meditor Group Ltd's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-11 |
| 13F-HR | 2024-01-04 |
| SC 13G/A | 2024-01-03 |
| 13F-HR | 2023-10-31 |
| 13F-HR | 2023-07-25 |
| 13F-HR | 2023-04-10 |
| 13F-HR | 2023-01-05 |
| SC 13G/A | 2023-01-04 |
| 13F-HR | 2022-11-07 |
| 13F-HR | 2022-07-18 |
View Meditor Group Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.